with relation to what Andy said yesterday in his interview, and just to start a new conversation....
Let's say Bioelectronics signs a licensing deal to roll out the retail operation and they continue with their research and development and offer a certain % of that to the licensing partner or someone like B Braun.
Who would like to throw around some numbers that would make sense in either/both scenarios.
I think that part of the interview was the most compelling for me.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.